These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 745590)

  • 1. Visual abnormalities following nitrosourea treatment.
    Louie AC; Turrisi AT; Muggia FM; Bono VH
    Med Pediatr Oncol; 1978; 5(1):245-7. PubMed ID: 745590
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nitrosourea-induced lung diseases].
    Massin F; Coudert B; Foucher P; Lombard JN; Reybet-Degat O; Jeannin L; Camus P
    Rev Mal Respir; 1992; 9(6):575-82. PubMed ID: 1470749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrosourea-associated pulmonary fibrosis.
    Hundley RF; Lukens JN
    Cancer Treat Rep; 1979; 63(11-12):2128-30. PubMed ID: 526951
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.
    Lohrmann HP; Lepp KA; Schreml W
    J Natl Cancer Inst; 1982 Apr; 68(4):541-7. PubMed ID: 6951071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrosoureas as single agents in the treatment of pulmonary cancer.
    Wolf J
    Cancer Treat Rep; 1976 Jun; 60(6):753-6. PubMed ID: 782697
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotoxicity of nitrosoureas.
    Schacht RG; Feiner HD; Gallo GR; Lieberman A; Baldwin DS
    Cancer; 1981 Sep; 48(6):1328-34. PubMed ID: 7272960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors.
    Robustelli della Cuna G; Paoletti P; Bernardo G; Knerich R; Butti G; Cuzzoni Q
    Neurosurgery; 1982 Sep; 11(3):408-11. PubMed ID: 6290930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nitrosoureas: an outline of clinical schedules and toxic effects.
    Wasserman TH
    Cancer Treat Rep; 1976 Jun; 60(6):709-11. PubMed ID: 954008
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute leukemia after adjuvant therapy of gastrointestinal cancer with semustine (methyl-CCNU).
    N Engl J Med; 1984 Apr; 310(16):1057-8. PubMed ID: 6708984
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect.
    Boice JD; Greene MH; Killen JY; Ellenberg SS; Fraumeni JF; Keehn RJ; McFadden E; Chen TT; Stablein D
    N Engl J Med; 1986 Jan; 314(2):119-20. PubMed ID: 3941685
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of nitrosourea compounds in cancer chemotherapy].
    Robak T
    Pol Tyg Lek; 1982 Sep; 37(36):1067-70. PubMed ID: 6763214
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephrotoxicity of methyl-CCNU.
    Nichols WC; Moertel CG
    N Engl J Med; 1979 Nov; 301(21):1181. PubMed ID: 492286
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas. A prospective study with statistical analysis.
    Defer G; Fauchon F; Schaison M; Chiras J; Brunet P
    Neuroradiology; 1991; 33(5):432-7. PubMed ID: 1749475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: acute leukemia after semustine (methyl-CCNU) therapy.
    Uphouse WJ; Oishi N
    Cancer Treat Rep; 1982 Jul; 66(7):1593-4. PubMed ID: 6953997
    [No Abstract]   [Full Text] [Related]  

  • 15. Methyl CCNU therapy linked leukemia.
    Shetty MR
    Cancer Chemother Pharmacol; 1981; 6(2):199. PubMed ID: 7307237
    [No Abstract]   [Full Text] [Related]  

  • 16. Unexpected pain syndrome during a phase I study of lv methyl-CCNU.
    Haas CD; Stephens RL; Leite CJ; Goodwin JW; Hoogstraten B
    Cancer Treat Rep; 1977 Oct; 61(7):1413-5. PubMed ID: 589605
    [No Abstract]   [Full Text] [Related]  

  • 17. Mallory-Weiss lesion following cancer chemotherapy.
    Enck RE
    Lancet; 1977 Oct; 2(8044):927-8. PubMed ID: 72263
    [No Abstract]   [Full Text] [Related]  

  • 18. Theophylline-induced lomustine toxicity.
    Zeltzer PM; Feig SA
    Lancet; 1979 Nov; 2(8149):960-1. PubMed ID: 91053
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal pulmonary toxic effects of lomustine.
    Dent RG
    Thorax; 1982 Aug; 37(8):627-9. PubMed ID: 7179192
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia.
    Cordonnier C; Vernant JP; Mital P; Lange F; Bernaudin JF; Rochant H
    Cancer; 1983 May; 51(10):1814-8. PubMed ID: 6572542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.